Johnson & Johnson said it would begin a final 60,000-person trial of a single-shot COVID-19 vaccine, which could prove easier to administer than rivals that require two inoculations.
J&J launches final study of COVID-19 vaccine
J&J launches final study of COVID-19 vaccine
Post A Comment:
0 comments:
Leave a comment. Thanks!